Preventing avoidable central line-associated bloodstream infections: Implications for probiotic administration and surveillance.
Internal Medicine, Cambridge Health Alliance, Cambridge, MA.
Sonja
S
Skljarevski
Clinical Pharmacy, Cambridge Health Alliance, Cambridge, MA. Electronic address: abarner@challiance.org.
Amanda
A
Barner
Internal Medicine, Cambridge Health Alliance, Cambridge, MA; Division of Infectious Diseases, Cambridge Health Alliance, Cambridge, MA; Harvard Medical School, Cambridge, MA.
Lou Ann
LA
Bruno-Murtha
D000368:Aged; D016470:Bacteremia / Q000517:prevention & control*; D055499:Catheter-Related Infections / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000382:microbiology / Q000628:therapy*; D004750:Enteral Nutrition; D005260:Female; D006801:Humans; D007778:Lactobacillus; D019936:Probiotics / Q000008:administration & dosage*